From: Structural studies on radiopharmaceutical DOTA-minigastrin analogue (CP04) complexes and their interaction with CCK2 receptor
[177Lu]Lu-CP04
[68Ga]Ga-CP04
n
6
4
Membrane-bound fraction [%]
4.10 ± 0.91
3.63 ± 0.78
Internalization [%]
74.82 ± 7.74
73.45 ± 10.22